| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 63.972 | 80.554 | 117.518 | 102.762 |
| Total Income - EUR | - | - | - | - | - | - | 63.972 | 81.521 | 121.753 | 103.265 |
| Total Expenses - EUR | - | - | - | - | - | - | 9.057 | 25.101 | 41.713 | 28.355 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 54.915 | 56.421 | 80.040 | 74.910 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 54.177 | 55.631 | 78.924 | 71.981 |
| Employees | - | - | - | - | - | - | 1 | 2 | 2 | 1 |
Check the financial reports for the company - Xolving Labs S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 910 | 507 | 993 | 1.446 |
| Current Assets | - | - | - | - | - | - | 71.638 | 76.822 | 97.571 | 91.975 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 59.715 | 66.667 | 89.884 | 87.578 |
| Cash | - | - | - | - | - | - | 11.923 | 10.155 | 7.687 | 4.397 |
| Shareholders Funds | - | - | - | - | - | - | 54.177 | 55.631 | 78.924 | 71.982 |
| Social Capital | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Debts | - | - | - | - | - | - | 18.370 | 21.698 | 19.640 | 21.440 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6210 - 6210" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Xolving Labs S.r.l.